Impact of Remote Cholecystectomy on Clinical Outcomes Following Pseudomonas aeruginosa Bloodstream Infection - Takeaways - MDSpire

Impact of Remote Cholecystectomy on Clinical Outcomes Following Pseudomonas aeruginosa Bloodstream Infection

  • By

  • Hanna K Bertucci

  • Lyndsey R Heise

  • Anne Kurze

  • Michael P Angarone

  • Alan R Hauser

  • Marc H Scheetz

  • Susheel Reddy

  • Kelly E R Bachta

  • November 12, 2025

  • 0 min

Share

  • 1

    Pseudomonas aeruginosa bloodstream infection (PABSI) mortality remains high despite advances in treatment, with a 30.1% composite 90-day mortality observed.

  • 2

    A retrospective cohort study found no significant differences in clinical outcomes between patients with or without a retained gallbladder.

  • 3

    Patients with PABSI and liver disease had significantly higher 90-day mortality compared to those without liver disease.

  • 4

    The presence of a gallbladder did not affect the antimicrobial resistance profile of P. aeruginosa isolates.

  • 5

    Overall, the study indicates that remote cholecystectomy does not influence PABSI outcomes or resistance patterns.

Original Source(s)

Impact of Remote Cholecystectomy on Clinical Outcomes Following Pseudomonas aeruginosa Bloodstream Infection

  • by Hanna K Bertucci, Lyndsey R Heise, Anne Kurze, Michael P Angarone, Alan R Hauser, Marc H Scheetz, Susheel Reddy, Kelly E R Bachta

  • November 12, 2025

Related Content

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Liver Supplements: Big Sales, Limited Evidence

Researchers evaluate how popular liver cleanse products are formulated and promoted in the US online marketplace.

Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients